Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Ironwood Pharmaceuticals, Inc.    IRWD

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsSector newsTweets 
Most relevant news about IRONWOOD PHARMACEUTICALS,
01/09 IRONWOOD PHARMACEUTICALS,INC. (NASDA : IRWD) Files An 8-K Results of Operations ..
01/09 IRONWOOD PHARMACEUTICALS,INC. (NASDA : IRWD) Files An 8-K Termination of a Mater..
01/09 IRONWOOD PHARMACEUTICALS : Demonstrates Strong Execution on Strategy to Build To..
01/06 ACHAOGEN : Appoints Halley Gilbert to Its Board of Directors
01/04 IRONWOOD PHARMACEUTICALS : Appoints Amy Schulman to Board of Directors
01/04 IRONWOOD PHARMACEUTICALS : IRWD) Gains on NDA
01/04 IRONWOOD PHARMACEUTICALS : Announces New Drug Application for DUZALLO™ (Fi..
01/03 IRONWOOD PHARMACEUTICALS : to Present at J.P. Morgan Healthcare Conference
2016 IRONWOOD PHARMACEUTICALS : and Allergan Report Topline Phase IIb Data Supporting..
2016 IRONWOOD PHARMACEUTICALS : and Allergan Report Topline Phase IIb Data Supporting..
2016 IRONWOOD PHARMACEUTICALS : Announces Approval of LINZESS® (linaclotide) in Japan..
2016 IRONWOOD PHARMACEUTICALS : Highlights ZURAMPIC® (lesinurad) Phase III Extension ..
2016 IRONWOOD PHARMACEUTICALS : to Present at Stifel 2016 Healthcare Conference
2016 IRONWOOD PHARMACEUTICALS : reports 3Q loss
2016 IRONWOOD PHARMACEUTICALS : Provides Third Quarter 2016 Investor Update
More most relevant news
All news about IRONWOOD PHARMACEUTICALS,
01/12 IRONWOOD PHARMACEUTICALS : to Present at J.P. Morgan Healthcare Conference
01/12 IRONWOOD PHARMACEUTICALS : Appoints Amy Schulman to Board of Directors
01/12 IRONWOOD PHARMACEUTICALS : Announces New Drug Application for DUZALLO™ Fix..
01/09 IRONWOOD PHARMACEUTICALS,INC. (NASDA : IRWD) Files An 8-K Results of Operations ..
01/09 IRONWOOD PHARMACEUTICALS INC : Results of Operations and Financial Condition, Fi..
01/09 IRONWOOD PHARMACEUTICALS,INC. (NASDA : IRWD) Files An 8-K Termination of a Mater..
01/09 IRONWOOD PHARMACEUTICALS : Demonstrates Strong Execution on Strategy to Build To..
01/06 ACHAOGEN : Appoints Halley Gilbert to Its Board of Directors
01/05 IRONWOOD PHARMACEUTICALS INC : Termination of a Material Definitive Agreement (f..
01/04 IRONWOOD PHARMACEUTICALS INC : Change in Directors or Principal Officers, Financ..
More news
Sector news : Biotechnology & Medical Research - NEC
01/13DJNOVARTIS : Supreme Court to Weigh How Soon Firms Can Sell Copycat Biotech Drugs
01/12 Investors in big pharma, biotech look to ride out Trump storm
01/12DJHot Stocks to Watch in the U.S. and Canada
01/10 Regeneron CEO says Amgen not putting patients first in patent dispute
01/09DJCELGENE : Anticipates Slowing Sales Growth for Main Drug Revlimid
01/06DJSanofi Investors Count Cost of Praluent Ruling -- Update
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
01/10 CymaBay Is Dirt Cheap, But Is It A Bargain?
01/10 Ironwood (IRWD) Investor Presentation - Slideshow
01/04 FDA to review Ironwood's marketing application for gout drug Duzallo, action ..
2016 Targeted delivery formulations of Linzess show positive effects in mid-stage ..
2016 Ironwood's Linzess OK'd in Japan to treat IBS-C; shares up 3%
2016 Synergy Pharma gives up big gains, now down nearly 7%
Latest Tweets
01/13Ironwood Pharmaceuticals's neutral rating reiterated at Wedbush. $13.00 PT.  
01/11Ironwood Pharmaceuticals downgraded by Zacks Investment Research to sell.  
01/10CymaBay Is Dirt Cheap, But Is It A Bargain?  
01/10Ironwood (IRWD) Investor Presentation - Slideshow  
01/10Get the latest ratings for $TFSL $ARC $FDEF $AAN $IRWD in your inbox with Mar.. 
More tweets
Qtime:35
Advertisement
Financials ($)
Sales 2016 260 M
EBIT 2016 -67,1 M
Net income 2016 -96,8 M
Debt 2016 103 M
Yield 2016 -
P/E ratio 2016 -
P/E ratio 2017
EV / Sales 2016 9,19x
EV / Sales 2017 7,13x
Capitalization 2 291 M
More Financials
Chart IRONWOOD PHARMACEUTICALS,
Duration : Period :
Ironwood Pharmaceuticals,  Technical Analysis Chart | IRWD | US46333X1081 | 4-Traders
Full-screen chart
Technical analysis trends IRONWOOD PHARMACE...
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 12
Average target price 15,8 $
Spread / Average Target 0,78%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Peter M. Hecht Chief Executive Officer & Director
Terrance G. McGuire Chairman
Thomas Graney Chief Financial Officer & SVP-Corporate Strategy
Mark G. Currie Chief Scientific Officer & Senior Vice President
Brian M. Cali Senior VP-Preclinical, Research & Development
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
IRONWOOD PHARMACEUTICA..2.49%2 291
INCYTE CORPORATION17.43%22 182
QUINTILES IMS HOLDINGS..1.46%18 995
CELLTRION, INC.--.--%10 712
LONZA GROUP AG4.65%9 715
ALKERMES PLC-0.22%8 428
More Results